Podcasts

BIO hosted a media briefing on Wednesday, June 30th, with Jim Greenwood and Rachel King, Co-Founder and CEO of GlycoMimetics, Inc. and member of BIO’s Executive Committee.

May is hepatitis awareness month. More than 5 million people in the U.S. are living with chronic hepatitis B or hepatitis C. But these two diseases receive limited attention in the general public and the health care system. Hepatitis C, for example, affects up to 3.9 million people, yet 75% are unaware they are infected. It's estimated that costs related to HCV infection will rise from $30 billion in 2009 to more than $85 billion in 2024.

BioPharm International interviews BIO's President and CEO, Jim Greenwood on the challenges facing the pharmaceutical industry and BIO's 2010 International Convention in Chicago.

Listen to the podcast

Dr. Allan Jarvis, vice president of corporate development at sanofi pasteur, discusses the vaccine track that they are sponsoring at this year's BIO International Convention, the type of partnerships that they're currently seeking, how important the Convention is to their partnering efforts, among other things. For more information on sanofi pasteur, please visit www.sanofipasteur.com.

Michael Werner, a partner at Holland & Knight law firm, discusses ethical issues facing biotechnology today and the session he is organizing on bioethics and business practices for the 2010 BIO International Convention.

Danny Levine of the Burrill Report conducted a podcast with BIO President & CEO Jim Greenwood today on BIO's public priorities for 2010. Discussion topics include what happens next with national health care reform, biosimilars, patent reform, and biofuels. You can listen to the podcast on the Burrill Report website at http://www.burrillreport.com/article-2090.html.

Patient advocacy groups have many different roles.  They are educators, they provide a support system for individuals and families of people living with illness, they lobby for increased research, and are increasingly providing funding to biotech companies to encourage further research and development of promising, and potentially life-saving therapies.  At the 2009 BIO International Convention, we met with patients  and patient advocates to learn more about how advocacy groups are working together with biotech researchers to promote innovative research and creation of therapies that may one d

Novozymes is an international corporation that is creating industrial biosolutions through over 700 products designed to improve industrial performance and safeguard the world's resources.  During a trip to their Franklinton, North Carolina-based facility, we learned about their work to create more efficient and environmentally friendly laundry detergents through the use of industrial enzymes.

Download to listen or view the podcast.

Do you ever wonder if the medicine you're taking is really helping to make you feel better? What if your doctor had a way to tell you exactly which drug and what dosage would best treat your illness?  Dr.